Wird geladen...

The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are widely used to treat HIV-1-infected individuals; indeed most first-line antiretroviral therapies typically include one NNRTI in combination with two nucleoside analogs. In 2008, the next-generation NNRTI etravirine was approved for the trea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Sluis-Cremer, Nicolas
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4147682/
https://ncbi.nlm.nih.gov/pubmed/25089538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v6082960
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!